Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
57
WELL.TO Quote, Financials, Valuation and Earnings
Last price:
$3.94
Seasonality move
:
11.62%
Day range:
$3.89 - $3.96
52-week range:
$3.58 - $7.36
Dividend yield:
0%
P/E ratio:
41.90x
P/S ratio:
0.82x
P/B ratio:
1.18x
Volume:
1.6M
Avg. volume:
1.7M
1-year change:
-44.79%
Market cap:
$995.2M
Revenue:
$919.7M
EPS (TTM):
-$0.17
Analysts' Opinion
-
Consensus RatingWELL Health Technologies Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $7.65, WELL Health Technologies Corp. has an estimated upside of 95.15% from its current price of $3.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.50 representing 100% downside risk from its current price of $3.92.
Fair Value
-
According to the consensus of 8 analysts, WELL Health Technologies Corp. has 95.15% upside to fair value with a price target of $7.65 per share.
WELL.TO vs. S&P 500
-
Over the past 5 trading days, WELL Health Technologies Corp. has underperformed the S&P 500 by -3.03% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
WELL Health Technologies Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
WELL Health Technologies Corp. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter WELL Health Technologies Corp. reported revenues of $364.6M.
Earnings Growth
-
WELL Health Technologies Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter WELL Health Technologies Corp. reported earnings per share of $0.02.
Enterprise value:
1.7B
EV / Invested capital:
1.04x
Price / LTM sales:
0.82x
EV / EBIT:
171.22x
EV / Revenue:
1.39x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-29.73x
Price / Operating cash flow:
135.78x
Enterprise value / EBITDA:
16.48x
Gross Profit (TTM):
$390.7M
Return On Assets:
-3.2%
Net Income Margin (TTM):
-4.9%
Return On Equity:
-6.26%
Return On Invested Capital:
-4.02%
Operating Margin:
9.13%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $701.3M | $916.2M | $1.2B | $234.1M | $364.6M | |
| Gross Profit | $293.4M | $313.3M | $390.7M | $77.2M | $139.3M | |
| Operating Income | $31.5M | $16.8M | $9.8M | $258K | $33.3M | |
| EBITDA | $89.6M | $84.9M | $102.3M | $17.7M | $59.8M | |
| Diluted EPS | -$0.03 | $0.20 | -$0.17 | -$0.36 | $0.02 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $145.7M | $166.5M | $162.8M | $314.9M | $344.7M | |
| Total Assets | $1.2B | $1.3B | $1.4B | $1.6B | $2B | |
| Current Liabilities | $142.2M | $149.7M | $137.6M | $277.2M | $372.6M | |
| Total Liabilities | $507.3M | $549.7M | $539.4M | $675.1M | $1B | |
| Total Equity | $649.1M | $793.3M | $819.6M | $918M | $993.5M | |
| Total Debt | $372.7M | $363.8M | $400M | $392.5M | $624.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $76.9M | -$20.8M | -$31.3M | -$6.5M | $27.2M | |
| Cash From Investing | -$105.6M | -$61.1M | -$123.8M | -$12.4M | -$25.6M | |
| Cash From Financing | $21.5M | $103M | $169.5M | $39M | -$18M | |
| Free Cash Flow | $70.9M | -$50.2M | -$56.7M | -$10.5M | $19.2M | |
WELL.TO
Sector
Market Cap
$995.2M
$28.4M
Price % of 52-Week High
53.26%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
-2.97%
-1.49%
1-Year Price Total Return
-44.79%
-16.67%
Beta (5-Year)
1.234
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.95
200-day SMA
Sell
Level
$4.49
Bollinger Bands (100)
Sell
Level
4.11 - 5.17
Chaikin Money Flow
Sell
Level
-1.2M
20-day SMA
Sell
Level
$3.92
Relative Strength Index (RSI14)
Sell
Level
42.75
ADX Line
Sell
Level
5.9
Williams %R
Neutral
Level
-68.2927
50-day SMA
Sell
Level
$4.35
MACD (12, 26)
Buy
Level
0.87
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
708.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.594)
Buy
CA Score
(Annual)
Level (-0.2566)
Sell
Beneish M-Score
(Annual)
Level (-1.6638)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (0.0022)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
WELL Health Technologies Corp. operates as digital healthcare company, which engages in owning and operating a portfolio of primary healthcare facilities. Its virtual services includes telehealth, electronic medical record, patien portal, ePharmacy, billing and RCM, cybersecurity, and digital apps.. The company was founded by Hamed Shahbazi on November 23, 2010 and is headquartered in Vancouver, Canada.
Stock Forecast FAQ
In the current month, WELL.TO has received 8 Buy ratings 0 Hold ratings, and 0 Sell ratings. The WELL.TO average analyst price target in the past 3 months is $7.65.
-
Where Will WELL Health Technologies Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that WELL Health Technologies Corp. share price will rise to $7.65 per share over the next 12 months.
-
What Do Analysts Say About WELL Health Technologies Corp.?
Analysts are divided on their view about WELL Health Technologies Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that WELL Health Technologies Corp. is a Sell and believe this share price will drop from its current level to $5.50.
-
What Is WELL Health Technologies Corp.'s Price Target?
The price target for WELL Health Technologies Corp. over the next 1-year time period is forecast to be $7.65 according to 8 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is WELL.TO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for WELL Health Technologies Corp. is a Buy. 8 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of WELL.TO?
You can purchase shares of WELL Health Technologies Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase WELL Health Technologies Corp. shares.
-
What Is The WELL Health Technologies Corp. Share Price Today?
WELL Health Technologies Corp. was last trading at $3.94 per share. This represents the most recent stock quote for WELL Health Technologies Corp.. Yesterday, WELL Health Technologies Corp. closed at $3.92 per share.
-
How To Buy WELL Health Technologies Corp. Stock Online?
In order to purchase WELL Health Technologies Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get WELL.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
WELL.TO
Sector
P/E ratio
41.90x
23.89x
PEG ratio
0.00x
-0.01x
P/B ratio
1.18x
1.81x
Price / LTM sales
0.82x
1.58x
Growth Metrics
WELL.TO
Sector
Revenue growth
55.72%
4.62%
Earnings growth
104.47%
10.7%
Revenue (5-year growth)
94.77%
6.5%
Earnings forecast
$0.10
-$0.21
Profitability
WELL.TO
Sector
Profitability FY 2024
$290.7M
$3.6M
Return on invested capital
-4.02%
-31.84%
Return on assets
-3.2%
-27.96%
Return on equity
-6.26%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
19
Estimated Next Earnings Date
Feb
5
Balance Sheet
WELL.TO
Sector
Total cash
$82.5M
$26.4M
Short term investments
--
$25.7M
Total assets
$1.8B
$76.9M
Long term debt
$624.1M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 4.54% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is up 0.09% over the past day.
Buy
69
QBTS alert for Dec 23
D-Wave Quantum, Inc. [QBTS] is down 8.48% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
